Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Atara Biotherapeutics (ATRA) announced that the FDA has placed a clinical hold on Atara’s active investigational new drug, or IND, ...

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

It takes courage to be our genuine selves, writes columnist Candace Semien, who shares a couple powerful prayers for lupus.

Study reveals fibromyalgia impacts nearly 20% of lupus patients, reducing quality of life and calling for improved diagnosis ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.